The GlaxoSmithKline logo is seen on top of GSK Asia House in Singapore March 21, 2018. — Reuters picLONDON, April 28 — GSK topped analysts’ expectations for first-quarter earnings as more people visited clinics for critical treatments such as HIV and routine shots once Covid-19 curbs eased, adding on Wednesday that plans to split into two were “well underway”.
Turnover for the three months to March fell 15 per cent to £7.42 billion at constant currency rates, while adjusted earnings stood at 22.9 pence per share, GSK, the world’s biggest vaccine maker by sales, said.company-compiled consensus analystsGSK said it would provide details on its plan to separate into an over-the-counter products business and another for prescription medicines and vaccines in June.